This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ellodi Pharmaceuticals, L.p.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Peter Richardson in Eosinophilic Esophagitis Treatment
Introduction
Peter Richardson is an accomplished inventor based in Blue Bell, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of eosinophilic esophagitis. His innovative approaches aim to improve patient outcomes while minimizing side effects.
Latest Patents
Peter Richardson holds a patent for "Methods of treating eosinophilic esophagitis and reducing candidiasis." This patent discloses methods for treating eosinophilic esophagitis with corticosteroids. The methods outlined in the patent result in reduced corticosteroid side effects, such as candidiasis. The patent provides detailed dosages, formulations, and methods for the administration of corticosteroids. He has 1 patent to his name.
Career Highlights
Peter Richardson is currently associated with Ellodi Pharmaceuticals, L.P., where he continues to work on innovative treatments. His expertise in the field has positioned him as a valuable asset to the company and the medical community.
Collaborations
Peter collaborates with various professionals in the field, including his coworker James Nezamis. Their combined efforts contribute to advancing research and development in the treatment of eosinophilic esophagitis.
Conclusion
Peter Richardson's work in developing methods for treating eosinophilic esophagitis showcases his commitment to innovation in medicine. His contributions are vital for improving patient care and reducing side effects associated with treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile